Clinical Trial Detail

NCT ID NCT02812667
Title Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lyudmila Bazhenova, M.D.
Indications

lung non-small cell carcinoma

Therapies

Nivolumab + Plinabulin

Age Groups: adult senior

No variant requirements are available.